InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Galvin Roy. Officer active across 2 companies, notably HAEMONETICS CORP. Cumulatively, 10 reports have been published. Activity tracked since 1 November 2023. The latest transaction was filed on 31 October 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Galvin Roy is EVP, Chief Commercial Officer at HAEMONETICS CORP and Haemonetics CORP. He has 10 filings in total, and the sampled recent filings run from 2022-11-03 to 2025-11-03, with transactions of nature Tax withholding; sum_buy_eur and sum_sell_eur are both 0.